Neo Ivy Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,770
Closed -$472K 334
2024
Q3
$472K Buy
+5,770
New +$445K 0.15% 188
2023
Q4
Sell
-3,600
Closed -$263K 360
2023
Q3
$263K Buy
+3,600
New +$243K 0.12% 216
2022
Q4
Sell
-1,741
Closed -$117K 432
2022
Q3
$117K Buy
1,741
+1,690
+3,314% +$107K 0.31% 130
2022
Q2
$3K Buy
+51
New +$3.27K 0.01% 364
2021
Q3
Sell
-2,763
Closed -$222K 546
2021
Q2
$222K Sell
2,763
-2,419
-47% -$184K 0.22% 163
2021
Q1
$352K Buy
5,182
+3,542
+216% +$278K 0.39% 84
2020
Q4
$114K Buy
1,640
+69
+4% +$4.29K 0.13% 242
2020
Q3
$80K Buy
+1,571
New +$86.3K 0.08% 312
2020
Q1
Sell
-2,198
Closed -$163K 497
2019
Q4
$163K Buy
+2,198
New +$137K 0.19% 170
2019
Q2
Sell
-3,664
Closed -$271K 333
2019
Q1
$271K Sell
3,664
-1,864
-34% -$131K 0.15% 186
2018
Q4
$330K Buy
+5,528
New +$446K 0.26% 166

Other funds holding HQY

Neo Ivy Capital Management's HQY Position: Q4 2024 in Review

Neo Ivy Capital Management sold out of HealthEquity (HQY) in Q4 2024, closing a stake of 5,770 shares — an estimated $472K sold.

Neo Ivy Capital Management first reported a position in HQY in Q4 2018 and held it in 11 quarters. The position peaked at $472K in Q3 2024. 441 funds tracked by Wall St. Rank hold HQY as of Q4 2024.

  • Neo Ivy Capital Management reported no remaining HealthEquity position as of Q4 2024 after selling out during the quarter.
  • Neo Ivy Capital Management sold 5,770 HealthEquity shares in Q4 2024, an estimated $472K.
  • Neo Ivy Capital Management first reported a position in HealthEquity in Q4 2018 and held it in 11 quarters.
  • Neo Ivy Capital Management's HealthEquity position peaked at $472K in Q3 2024.
  • 441 funds tracked by Wall St. Rank held HealthEquity as of Q4 2024.

Based on Neo Ivy Capital Management's 13F filing for Q4 2024, filed 18 Feb 2025.